Cost effectiveness of a protocol using palivizumab in preterm infants

Objective: The main objective was to evaluate the cost-effectiveness of protocol use of palivizumab in premature established by consensus in our Hospital comparing it based on the recommendations of various Scientific Societies. As a secondary objective risk factors and severity of hospitalized pat...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Farmacia Hospitalaria
Główni autorzy: Yolanda Hernández-Gago, Marina Lombardero-Pin, Casilda Ortega de la Cruz, Pablo A Maciuniak, Alicia Díez del Pino
Format: Artigo
Język:Inglês
Wydane: Sociedad Española de Farmacia Hospitalaria 2017
Hasła przedmiotowe:
Medicina
Cost
Neonate
Premature
Palivizumab
effectiveness
Dostęp online:https://www.redalyc.org/articulo.oa?id=365962268003
https://www.redalyc.org/journal/3659/365962268003/
https://www.redalyc.org/journal/3659/365962268003/html/
https://www.redalyc.org/journal/3659/365962268003/365962268003.epub
https://www.redalyc.org/journal/3659/365962268003/movil
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy